SEMA6D and lip and oral cavity carcinoma: Here, we discovered that Sema6d deficiency suppressed tumor progression via increased cytotoxic CD8+ T cell infiltration into tumors in a murine oral cancer model using MOC2 cells without endogenous Sema6d expression.